PPCB Return on Tangible Equity | PROPANC BIOPHARMA, INC.

PROPANC BIOPHARMA, INC. (PPCB) Return on Tangible Equity

2026-03-31: Return Tang Equity -186.82%.
2025-12-31: Return Tang Equity -632.09%.
2025-09-30: Return Tang Equity -441.52%.
2025-06-30: Return Tang Equity -423.72%.

Complete source-backed return tang equity history.

Available history: 2009-06-30 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	-186.82%
2025-12-31	-632.09%
2025-09-30	-441.52%
2025-06-30	-423.72%
2025-03-31	-305.16%
2024-12-31	40.15%
2024-09-30	44.40%
2024-06-30	48.17%
2024-03-31	59.74%
2023-12-31	69.96%
2023-09-30	80.09%
2023-06-30	85.35%
2023-03-31	95.78%
2022-12-31	84.73%
2022-09-30	100.62%
2022-06-30	87.91%
2022-03-31	85.92%
2021-12-31	84.89%
2021-09-30	90.65%
2021-06-30	66.04%
2021-03-31	1.43%
2020-12-31	61.28%
2020-09-30	113.56%
2020-06-30	130.19%
2020-03-31	155.69%
2019-12-31	97.72%
2019-09-30	112.85%
2019-06-30	133.88%
2019-03-31	163.47%
2018-12-31	166.20%
2018-09-30	130.27%
2018-06-30	104.25%
2018-03-31	107.05%
2017-12-31	99.73%
2017-09-30	128.97%
2017-06-30	144.58%
2017-03-31	192.83%
2016-12-31	257.05%
2016-09-30	536.23%
2016-06-30	366.83%
2016-03-31	237.99%
2015-12-31	199.11%
2015-09-30	108.89%
2015-06-30	111.66%
2015-03-31	97.28%
2014-12-31	75.28%
2014-09-30	58.36%
2014-06-30	58.90%
2014-03-31	71.80%
2013-12-31	105.43%
2013-09-30	124.88%
2013-06-30	182.06%
2013-03-31	505.04%
2012-12-31	1016.04%
2012-09-30	1453.27%
2012-06-30	2127.01%
2012-03-31	-568.84%

Annual Return Tang Equity

Date	Return Tang Equity
2025-06-30	-423.72%
2024-06-30	48.17%
2023-06-30	85.35%
2022-06-30	87.91%
2021-06-30	66.04%
2020-06-30	130.19%
2019-06-30	133.88%
2018-06-30	104.25%
2017-06-30	144.58%
2016-06-30	366.83%
2015-06-30	111.76%
2014-06-30	58.90%
2013-06-30	182.04%
2012-06-30	2125.67%
2011-06-30	-20.48%
2010-06-30	450.76%
2009-06-30	108.42%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)		$0.032B
NANOVIRICIDES, INC. (NNVC)	United States	$0.031B
BeyondSpring Inc. (BYSI)	United States	$0.031B	-10.95
Context Therapeutics Inc. (CNTX)	United States	$0.034B	-1.10
ROCKWELL MEDICAL, INC. (RMTI)	United States	$0.035B
IGC Pharma, Inc. (IGC)	United States	$0.029B	-5.98
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30
Seres Therapeutics, Inc. (MCRB)	United States	$0.036B	-3.45